Potential Sanfilippo Treatment, SLS-005, Advances as Orphan Drug in EU

The Committee for Orphan Medicinal Products, a branch of the European Medicines Agency (EMA), favours than designating SLS-005 (trehalose) an orphan drug as a potential treatment for Sanfilippo syndrome, Seelos Therapeutics, its developer, announced.

Want to read more?

Subscribe to ad.org.au to keep reading this exclusive post.

Subscribe Now